Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups

April 11, 2024 06:42 PM EDT | By News File Corp
 Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups
Image source: News File Corp

Irvine, California--(Newsfile Corp. - April 11, 2024) - University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.

The Golden Ticket competition seeks to accelerate the research and development endeavors of startup aesthetics enterprises and offers the winner free lab space for one year at ULP with access to state-of-the-art research equipment, professional support staff, conference rooms, and a vibrant, collaborative community to support the sharing of ideas. Winners also receive unparalleled opportunities to engage with industry mentors, including scientific and business leaders from Allergan Aesthetics, and complimentary memberships to prominent life sciences trade associations.

"Advancing the standard of care within aesthetic medicine requires us to discover and develop novel innovations into products with strong safety profiles and meaningful patient impact," said Darin Messina, Ph.D., Senior Vice President, Aesthetics R&D, AbbVie. "Allergan Aesthetics is once again proud to sponsor ULP's Golden Ticket initiative and invest in supporting entrepreneurial visionaries who share that mission and are willing to challenge existing thinking to create cutting-edge platforms."

Applications are now open and close on July 8, 2024. During the application period, applicants will have access to topic-specific webinars presented by Allergan Aesthetics and other esteemed industry mentors. Selected finalists will have the opportunity to pitch live at the Demo Day scheduled for September 10, 2024, in Irvine, California, where the winner will be revealed.

For more information and to apply, visit www.universitylabpartners.org/our-events/golden-ticket-applications-open.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10460/205094_92ba8dbd14477829_003.jpg

University Lab Partners state-of-the-art wet laboratory

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10460/205094_92ba8dbd14477829_003full.jpg

About University Lab Partners

University Lab Partners (ULP) is a premier, nonprofit, wet lab incubator located in Orange County, CA. ULP operates 2 facilities in Irvine and Aliso Viejo, CA. ULP offers highly-equipped wet lab facilities along with the benefits of peer-to-peer interactions among a life science-focused entrepreneurial community. For more information, visit www.universitylabpartners.org.

About Allergan Aesthetics

At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com.

Media Contact:

Karin Koch | Executive Director | [email protected] | 949-732-4290

SOURCE University Lab Partners

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/205094


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media Incorporated (“Kalkine Media, we or us”), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used in the Content are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.